Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A járványokról [Thomas Jordan, Despre epidemii], traducere si note Magyar László András, ed. Robert Offner, Budapest: Gondolat, 2022, 405 p. (Edit Szegedi)

View through CrossRef
Review of: Thomas Jordan, A járványokról [Thomas Jordan, Despre epidemii], traducere și note Magyar László András, ed. Robert Offner, Budapest: Gondolat, 2022, 405 p.
Title: A járványokról [Thomas Jordan, Despre epidemii], traducere si note Magyar László András, ed. Robert Offner, Budapest: Gondolat, 2022, 405 p. (Edit Szegedi)
Description:
Review of: Thomas Jordan, A járványokról [Thomas Jordan, Despre epidemii], traducere și note Magyar László András, ed.
Robert Offner, Budapest: Gondolat, 2022, 405 p.

Related Results

If I Had Possession over Judgment Day: Augmenting Robert Johnson
If I Had Possession over Judgment Day: Augmenting Robert Johnson
augmentvb [ɔːgˈmɛnt]1. to make or become greater in number, amount, strength, etc.; increase2. Music: to increase (a major or perfect interval) by a semitone (Collins English Dicti...
Ary Scheffer, een Nederlandse Fransman
Ary Scheffer, een Nederlandse Fransman
AbstractAry Scheffer (1795-1858) is so generally included in the French School (Note 2)- unsurprisingly, since his career was confined almost entirely to Paris - that the fact that...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Pieter Saenredam: zijn boekenbezit en zijn relatie met de landmeter Pieter Wils
Pieter Saenredam: zijn boekenbezit en zijn relatie met de landmeter Pieter Wils
AbstractAn earlier article on Saenredam's construction drawings (Note, 1 ) left open the question of how he obtained his knowledge of perspective. His teacher Frans de Grebber (Not...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...

Back to Top